Dr. André Habel starts at GeneQuine as Head of Manufacturing [ 14 Oct 2013 ]
The seasoned expert in GMP manufacturing of viral agents, Dr. André Habel, is GeneQuine's newest addition to the management team.
GQ-201 as minor use or minor species product classified [ 10 Oct 2013 ]
GeneQuine received a positive decision by EMA's Committee for Medicinal Products for Veterinary Use (CVMP) on classification of GeneQuine's lead candidate GQ-201 as product for minor use or minor species (MUMS).
GeneQuine classified as SME [ 28 May 2013 ]
The European Medicines Agency (EMA) classified GeneQuine as SME (micro, small and medium-sized enterprise).